News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,281 Results
Type
Article (49646)
Company Profile (278)
Press Release (682357)
Section
Business (212248)
Career Advice (2098)
Deals (36532)
Drug Delivery (102)
Drug Development (83576)
Employer Resources (171)
FDA (16954)
Job Trends (15699)
News (359140)
Policy (34651)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2773)
Accelerated approval (2)
Adcomms (23)
Allergies (81)
Alliances (51538)
ALS (83)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (104)
Approvals (16936)
Artificial intelligence (238)
Autoimmune disease (12)
Automation (14)
Bankruptcy (372)
Best Places to Work (12096)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (191)
Bladder cancer (52)
Brain cancer (25)
Breast cancer (249)
Cancer (1885)
Cardiovascular disease (149)
Career advice (1757)
Career pathing (29)
CAR-T (135)
Cell therapy (384)
Cervical cancer (16)
Clinical research (67417)
Collaboration (743)
Compensation (420)
Complete response letters (20)
COVID-19 (2704)
CRISPR (35)
C-suite (198)
Cystic fibrosis (98)
Data (1795)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (234)
Diagnostics (6521)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (108)
Drug pricing (101)
Drug shortages (28)
Duchenne muscular dystrophy (72)
Earnings (87994)
Editorial (33)
Employer branding (21)
Employer resources (147)
Events (116339)
Executive appointments (623)
FDA (17994)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (663)
Gene editing (95)
Generative AI (24)
Gene therapy (270)
GLP-1 (717)
Government (4641)
Grass and pollen (4)
Guidances (47)
Healthcare (19883)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (94)
Indications (25)
Infectious disease (2830)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (72)
Interviews (319)
IPO (16849)
IRA (41)
Job creations (4043)
Job search strategy (1501)
Kidney cancer (9)
Labor market (30)
Layoffs (460)
Leadership (15)
Legal (8450)
Liver cancer (74)
Lung cancer (275)
Lymphoma (124)
Machine learning (2)
Management (58)
Manufacturing (259)
MASH (59)
Medical device (14300)
Medtech (14305)
Mergers & acquisitions (20116)
Metabolic disorders (629)
Multiple sclerosis (64)
NASH (16)
Neurodegenerative disease (78)
Neuropsychiatric disorders (27)
Neuroscience (1855)
NextGen: Class of 2025 (6911)
Non-profit (4737)
Northern California (2282)
Now hiring (36)
Obesity (351)
Opinion (211)
Ovarian cancer (62)
Pain (76)
Pancreatic cancer (73)
Parkinson's disease (129)
Partnered (17)
Patents (186)
Patient recruitment (86)
Peanut (47)
People (59827)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (20967)
Phase II (29626)
Phase III (22135)
Pipeline (848)
Podcasts (54)
Policy (106)
Postmarket research (2741)
Preclinical (8890)
Press Release (67)
Prostate cancer (89)
Psychedelics (32)
Radiopharmaceuticals (253)
Rare diseases (353)
Real estate (6297)
Recruiting (65)
Regulatory (23462)
Reports (43)
Research institute (2478)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (68)
Series A (115)
Series B (71)
Service/supplier (13)
Sickle cell disease (50)
Southern California (1978)
Special edition (14)
Sponsored (30)
Startups (3826)
State (2)
Stomach cancer (13)
Supply chain (61)
The Weekly (28)
United States (20457)
Vaccines (677)
Venture capitalists (36)
Webinars (12)
Weight loss (247)
Women's health (34)
Worklife (14)
Date
Today (117)
Last 7 days (631)
Last 30 days (3078)
Last 365 days (34842)
2025 (6602)
2024 (36112)
2023 (41151)
2022 (52384)
2021 (57102)
2020 (55916)
2019 (48800)
2018 (36946)
2017 (33750)
2016 (33575)
2015 (39617)
2014 (33328)
2013 (28568)
2012 (30857)
2011 (31558)
2010 (29926)
Location
Africa (794)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (40777)
Australia (6725)
California (5245)
Canada (1812)
China (439)
Colorado (246)
Connecticut (266)
Delaware (121)
Europe (88280)
Florida (778)
Georgia (189)
Idaho (61)
Illinois (506)
India (22)
Indiana (288)
Iowa (7)
Japan (131)
Kansas (102)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (833)
Massachusetts (4019)
Michigan (211)
Minnesota (368)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (67)
New Jersey (1507)
New Mexico (29)
New York (1505)
North Carolina (948)
North Dakota (7)
Northern California (2282)
Ohio (183)
Oklahoma (13)
Oregon (34)
Pennsylvania (1189)
Puerto Rico (7)
Rhode Island (26)
South America (1184)
South Carolina (17)
South Dakota (1)
Southern California (1978)
Tennessee (89)
Texas (779)
Utah (164)
Virginia (126)
Washington D.C. (60)
Washington State (511)
West Virginia (3)
Wisconsin (48)
732,281 Results for "fuse medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fuse Oncology Establishes Clinical Liaison Council
March 10, 2025
·
2 min read
Press Releases
Fuse Vectors secures $5.2m to advance cell-free gene therapy technology, led by HCVC
February 26, 2025
·
7 min read
Lone Star Bio
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its quarterly report on Form 10-Q for the quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”).
August 15, 2023
·
10 min read
Lone Star Bio
Fuse Medical, Inc. Fiscal Year 2022 Financial Results
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its annual report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission (“SEC”) on April 14, 2023.
April 18, 2023
·
11 min read
Business
Fuse Oncology Announces Strategic Collaboration with Radiation Oncology Leader
Fuse Oncology (Fuse), a leading innovator in cutting-edge radiation oncology solutions, announced today a strategic collaboration with the University of Michigan, a recognized leader in radiation oncology.
December 14, 2023
·
2 min read
Business
Fuse Medical, Inc. Announces Third Quarter 2022 Financial Results
Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) announced for its third quarter ended September 30, 2022 and that it has filed its quarterly report on Form 10-Q for the quarter ended September 30, 2022 with the Securities and Exchange Commission (“SEC”) on November 14, 2022.
November 15, 2022
·
11 min read
Bio NC
Fuse Oncology Unveils FuseDocs: Newest RadOnc Solution for Streamlining Clinical Documentation for Radiation Oncologists
Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their latest pioneering product, FuseDocs, today.
September 29, 2023
·
3 min read
Bio NC
Global Leader Advancing Cancer Treatment, Dr. Christel Smith, Joins Fuse Oncology as Chief Technology Officer
Fuse Oncology, a trailblazing leader in radiation oncology software solutions, is pleased to announce the appointment of Dr. Christel Smith as its new Chief Technology Officer.
November 20, 2023
·
3 min read
Biotech Bay
Providence Medical Technology Announces Completion of Enrollment in the FUSE Clinical Study for High-Risk Cervical Fusion Patients
Providence Medical Technology, Inc. (PMT) today announced the close of enrollment in its FUSE Study — a prospective, multicenter, randomized, Investigational Device Exemption (IDE) clinical study evaluating the safety and effectiveness of its Posterior Cervical Stabilization System (PCSS) in 3-level cervical fusion patients.
May 11, 2023
·
5 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
March 6, 2025
·
1 min read
1 of 73,229
Next
